Antoine Yver

2022

In 2022, Antoine Yver earned a total compensation of $2.5M as Chairman of Development at Centessa Pharmaceuticals plc, a 85% decrease compared to previous year.

Compensation breakdown

Bonus$196,650
Option Awards$1,273,882
Salary$517,500
Stock Awards$517,000
Other$12,200
Total$2,517,232

Yver received $1.3M in option awards, accounting for 51% of the total pay in 2022.

Yver also received $196.7K in bonus, $517.5K in salary, $517K in stock awards and $12.2K in other compensation.

Rankings

In 2022, Antoine Yver's compensation ranked 1,446th out of 5,756 executives tracked by ExecPay. In other words, Yver earned more than 74.9% of executives.

ClassificationRankingPercentile
All
1,446
out of 5,756
75th
Division
Manufacturing
720
out of 3,133
77th
Major group
Chemicals And Allied Products
280
out of 1,419
80th
Industry group
Drugs
259
out of 1,320
80th
Industry
Pharmaceutical Preparations
182
out of 966
81st
Source: SEC filing on May 9, 2024.

Yver's colleagues

We found four more compensation records of executives who worked with Antoine Yver at Centessa Pharmaceuticals plc in 2022.

2022

Saurabh Saha

Centessa Pharmaceuticals plc

Chief Executive Officer

2022

Gregory Weinhoff

Centessa Pharmaceuticals plc

Chief Financial Officer

2022

David Chao

Centessa Pharmaceuticals plc

Chief Administrative Officer

2022

David Grainger

Centessa Pharmaceuticals plc

Former Chief Innovation Officer

News

In-depth

You may also like